BMS-830216

DB14787InvestigationalSmall molecule

BMS-830216 is under investigation in clinical trial NCT00909766 (Safety, Pharmacokinetics and Pharmacodynamics Study to Evaluate BMS-830216 in Obese Subjects).

Formula / weight: C₂₄H₂₂ClN₂O₇PS · 548.93 g/mol (avg)
Code names: BMS-830216

Resolves to

Compound

UNIIISL723GVQ8CAS1197420-06-6ChEMBLCHEMBL2147475

Structure

InChIKeyYDTUJCNTIMWHPJ-NRFANRHFSA-NSMILESCOC1=CC(=CC=C1OC[C@H](OP(O)(O)=O)C1CC1)N1C=NC2=C(SC(=C2)C2=CC=C(Cl)C=C2)C1=O

Targets

Q99705MCHR1

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with BMS-830216, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account